Dennis C Shrieve MD FASTRO
Professor of Radiation Oncology, University Utah
Join to View Full Profile
1950 Circle of Hope DrSte 1570Salt Lake City, UT 84112
Phone+1 801-581-8793
Fax+1 801-585-0151
Dr. Shrieve is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Radiation Oncology, 1990 - 1993- University of California (San Francisco)Internship, Internal Medicine, 1989 - 1990
University of Miami Leonard M. Miller School of MedicineClass of 1989
Certifications & Licensure
UT State Medical License 2000 - 2026
CA State Medical License 1991 - 2024
MA State Medical License 1993 - 2019
AR State Medical License 1997 - 2000
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Fellow American College of Radiology
- Join now to see all
Clinical Trials
- Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma Start of enrollment: 2005 Sep 01
- Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery Start of enrollment: 2011 Oct 01
- Stereotactic Radiosurgery Dose Escalation for Brain Metastases Start of enrollment: 2015 May 07
Publications & Presentations
PubMed
- Gross Tumor and Intracranial Control Benefits with Fractionated Radiotherapy Compared with Stereotactic Radiosurgery for Patients with WHO Grade 2 Meningioma.Nicholas Gravbrot, Calvin B Rock, Christopher R Weil, Christian B Rock, Lindsay M Burt
World Neurosurgery. 2024-08-01 - D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide.William B McKean, Jingye Yang, Kenneth Boucher, Dennis C Shrieve, Gita Suneja
Neuro-Oncology Advances. 2024-04-23 - The importance of considering competing risks in recurrence analysis of intracranial meningioma.Christian Mirian, Lasse Rehné Jensen, Tareq A Juratli, Andrea Daniela Maier, Sverre H Torp
Journal of Neuro-Oncology. 2024-02-01
Press Mentions
Proton Therapy Opens in UtahJune 23rd, 2021
Synchrocyclotron for the MEVION S250i Proton Therapy System Delivered to Huntsman Cancer InstituteApril 1st, 2020
Huntsman Cancer Institute Breaks Ground on Sophisticated Radiation Facility Named for Sen. HatchNovember 20th, 2018- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
